SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891293-10-000006
Filing Date
2010-03-26
Accepted
2010-03-26 19:12:23
Documents
1
Period of Report
2010-03-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3934
  Complete submission text file 0000891293-10-000006.txt   5708
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Issuer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 501 ELLIOT AVENUE WEST SUITE 400 SEATTLE WA 98119
Business Address
BIANCO LOUIS A (Reporting) CIK: 0001204260 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12465 | Film No.: 10709015